Hypofractionated image guided radiation therapy followed by prostate seed implant boost for men with newly diagnosed intermediate and high risk adenocarcinoma of the prostate: Preliminary results of a phase 2 prospective study.

Journal: Advances in radiation oncology
Published Date:

Abstract

PURPOSE: A phase 2 protocol was designed and implemented to assess the toxicity and efficacy of hypofractionated image guided intensity modulated radiation therapy (IG-IMRT) combined with low-dose rate Pd prostate seed implant for treatment of localized intermediate- and high-risk adenocarcinoma of the prostate.

Authors

  • Steven Gresswell
    Division of Radiation Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania.
  • Rodney E Wegner
    Division of Radiation Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania.
  • Day Werts
    Division of Radiation Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania.
  • Ralph Miller
    Division of Urology, Allegheny General Hospital, Pittsburgh, Pennsylvania.
  • Russell Fuhrer
    Division of Radiation Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania.

Keywords

No keywords available for this article.